| Authors: |
Leleu X; Hematology, CIC 1082, U1313, CHU, University, Poitiers, France. xavier.leleu@chu-poitiers.fr., Hulin C; CHU, Bordeaux, France., Lambert J; SBIM, Saint-Louis Hospital, Paris, France., Bobin A; Hematology, CIC 1082, U1313, CHU, University, Poitiers, France., Perrot A; University Hospital, iUCT Oncopole, Toulouse, France., Karlin L; Hôpital Lyon Sud, Pierre-Benite, France., Roussel M; Hematology, CHU, Limoges, France., Montes L; Hematology, CHU, Amiens, France., Cherel B; CH Bretagne Atlantique, Vannes, France., Chalopin T; Hematology, CHU, Tours, France., Slama B; Hospital center, Avignon, France., Chretien ML; Hematology, University Hospital, Inserm U1231, University of Burgundy Franche-Comté, Dijon, France., Laribi K; Hematology, CH, Le Mans, France., Dingremont C; Internal Medicine, Tarbes-Lourdes Hospital, Tarbes, France., Roul C; CH La Rochelle, La Rochelle, France., Mariette C; Hematology, CHU, Grenoble, France., Rigaudeau S; Hématologie - Le Chesnay, CH Versaille, Paris, France., Calmettes C; CH, Périgueux, France., Dib M; University Hospital, Angers, France., Tiab M; Hematology, CH Departemental de La Roche-sur-Yon, La Roche-sur-Yon, France., Vincent L; CHU, Montpellier, France., Delaunay J; Hôpital privé du confluent 2, Nantes, France., Santagostino A; Hematology, CH, Troyes, France., Macro M; Hematology, IHBN - CHU, Caen, France., Bourgeois E; GHICL, Lille, France., Orsini-Piocelle F; Hématologie, CH, Annecy Genevois, France., Gay J; Hematology, CH de la côte basque, Bayonne, France., Bareau B; Hematology, Les Hôpitaux Privés Rennais Cesson Sévigné - Vivalto Santé, Cesson Sévigné, France., Bigot N; SBIM, Saint-Louis Hospital, Paris, France., Vergez F; Unit for Genomics in Myeloma, iUCT Oncopole, Toulouse, France., Lebreton P; Hematology, CH, Le Havre, France., Tabrizi R; Hematology, CHI de Mont De Marsan, Mont-de-Marsan, France., Waultier-Rascalou A; Hematology, CHU, Nîmes, France., Frenzel L; Hematology, Necker Hospital, Paris, France., Le Calloch R; Hematology, CH de Cornouaille, Quimper Concarneau, Concarneau, France., Chalayer E; Hematology, CHU, Saint-Etienne, France., Braun T; Hematology, Avicenne hospital APHP, Bobigny, France., Lachenal F; CH Pierre Oudot, Bourgoin-Jallieu, France., Corm S; Medipole de Savoie, Challes les Eaux, France., Kennel C; CH William Morey, Chalon sur Saône, France., Belkhir R; Rheumatology, Hopital Bicetre, AP-HP, Universite Paris Saclay, Paris, France., Bladé JS; Onco-Hematology Department, HIA Sainte Anne, Toulon, France., Joly B; CH Sud Francilien, Corbeil Essonnes, France., Richez-Olivier V; CHU de Nice, Nice, France., Gardeney H; Hematology, CIC 1082, U1313, CHU, University, Poitiers, France., Demarquette H; Hematology, CH, Dunkerque, France., Robu-Cretu D; Hematology, CH, Lens, France., Garderet L; Hopital Pitié Salpetriere, hématologie APHP, Paris, France., Newinger-Porte M; Hôpital Emile Muller, Mulhouse, France., Kasmi A; DRC, CHU, Poitiers, France., Royer B; Hôpital Saint-Louis, Paris, France., Decaux O; Hematology, UMR U1236, University Hospital, Rennes, France., Arnulf B; Hôpital Saint-Louis, Paris, France., Belhadj K; C.H.U. Henri Mondor, Créteil, France., Touzeau C; Hématologie, CHU Hotel Dieu Université, Nantes, France., Mohty M; Hematology, Sorbonne University, Saint-Antoine Hôpital (AP-HP), UMRs 938, Paris, France., Manier S; Hematology, University Hospital Inserm U-S1277 and CNRS UMR9020, Lille, France., Moreau P; Hématologie, CHU Hotel Dieu Université, Nantes, France., Avet-Loiseau H; Unit for Genomics in Myeloma, iUCT Oncopole, Toulouse, France., Corre J; Unit for Genomics in Myeloma, iUCT Oncopole, Toulouse, France., Facon T; Hematology, University Hospital Inserm U-S1277 and CNRS UMR9020, Lille, France. |
